A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studies.


Journal

Journal of biopharmaceutical statistics
ISSN: 1520-5711
Titre abrégé: J Biopharm Stat
Pays: England
ID NLM: 9200436

Informations de publication

Date de publication:
02 01 2023
Historique:
pubmed: 2 6 2022
medline: 6 1 2023
entrez: 1 6 2022
Statut: ppublish

Résumé

Clinical studies are generally required to characterize the accuracy of new diagnostic tests. In some cases, historical data are available from a predicate device, which is directly relevant to the new test. If this data can be appropriately incorporated into the new test study design, there is an opportunity to reduce the sample size and trial duration for the new test. One approach to achieve this is the Bayesian power prior method, which allows for the historical information to be down-weighted via a power parameter. We propose a dynamic method to calculate the power parameter based on first comparing the data between the historical and new data sources using a one-sided comparison, and second mapping the comparison probability through a scaled-Weibull discount function to tune the effective sample size borrowed. This pragmatic and conservative approach is embedded in an adaptive trial framework allowing for the trial to stop early for success. An example is presented for a new test developed to detect Methicillin-resistant

Identifiants

pubmed: 35649152
doi: 10.1080/10543406.2022.2080690
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-89

Auteurs

Graeme L Hickey (GL)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Valentin Parvu (V)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Yongqiang Zhang (Y)

Thrive, EXACT Sciences Corp, Cambridge, Massachusetts, USA.

Charles K Cooper (CK)

Siemens Healthcare Diagnostics, Siemens Healthineers, Tarrytown, New York, USA.

Ying Wan (Y)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH